Source: centralcharts

Press Release: CARsgen : CARsgen Announces the Initiation of an Investigator-Initiated Trial for an Allogeneic CD19/CD20 CAR-T Therapy

CARsgen Announces the Initiation of an Investigator-Initiated Trial for an Allogeneic CD19/CD20 CAR-T Therapy PR Newswire SHANGHAI, Dec. 31, 2024 SHANGHAI ,

Read full article »
CARsgen's Competitors | CARsgen's News | CARsgen's Financials
Stay up-to-date with the latest news on CARsgen
Annual Revenue
$100K-5.0M
Employees
500-1.0K
Zonghai Li's photo - CEO of CARsgen

CEO

Zonghai Li

CEO Approval Rating

90/100

Read more
Stay up-to-date with the latest news on CARsgen